IP Library Granted Patent US 11,523,934
Granted Patent B2
US 11,523,934 · App. 16/904,056 · Granted Dec 13, 2022

Method and system to facilitate the growth of desired bacteria in a human's mouth

Inventors: Joseph E. Kovarik (Englewood, CO); Katherine Rose Kovarik (Englewood, CO)
Assignee: Seed Health, Inc.
A61F5/566
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,523,934
App. No.
16/904,056
Granted
Dec 13, 2022
Kind
B2
Abstract

A method to facilitate the growth of desired bacteria in a human's mouth by using a bioadhesive strip that has an encapsulated feature containing at least one bacteria that has one of a pathogenic or toxic element excised using a clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein (Cas) system or a CRISPR from Prevotella and Francisella 1 (Cpf1) system, and in particular, using oral strips that adhere to surfaces in the oral cavity and that include at least one of xylitol, Lachnospira, Veillonella, Faecalibacterium and/or Rothia bacteria.

Claims (24)

1. A method to facilitate the growth of desired bacteria in a human's mouth to limit the number of pathogenic bacteria, to maintain oral health and to establish a biofilm in a human subject's mouth, comprising,

after a human subject has cleaned their teeth, killing gram negative bacteria that are associated with periodontitis;

providing to the human subject a bacterial composition comprising beneficial bacteria adapted to form a biofilm, said beneficial bacteria comprising a bacterium of the genus Rothia , and wherein said bacterial composition does not inhibit growth of a bacterium of species Lactobacillus salivarius , and wherein said step of killing comprises using a clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein (Cas) system or a CRISPR from Prevotella and Francisella 1 (Cpf1) system.

2. The method as set forth in claim 1 , wherein said beneficial bacteria is provided on an oral strip.

3. The method as set forth in claim 1 , wherein said strip has a first side and a second side, said second side having a bioadhesive that is adapted to bind to a mucosal membrane of the human subject for at least 1 hour while inside the human subject's mouth.

4. The method as set forth in claim 1 , wherein said beneficial bacteria further comprises Lactobacillus reuteri in an amount sufficient to induce oxytocin production.

5. The method as set forth in claim 1 , wherein said gram negative bacteria comprises Treponema denticola.

6. The method as set forth in claim 1 , wherein the bacterial composition is administered orally.

7. The method as set forth in claim 1 , wherein the bacterial composition does not inhibit growth of a second bacterium selected from at least one of the species Streptococcus mutans and Lactobacillus fermentum.

8. The method of claim 1 , wherein the step of administering comprises providing a buccal bioadhesive strip having a first side and a second side, the second side having a bioadhesive that is adapted to bind to a mucosal membrane for at least 1 hour while inside the human subject's mouth, wherein said strip includes at least one encapsulated feature containing said bacterial composition.

9. The method as set forth in claim 1 , wherein the bacterial composition does not inhibit growth of a bacterium of species Lactobacillus fermentum.

10. The method as set forth in claim 1 , wherein the method further comprises administering a prebiotic to the human.

11. The method as set forth in claim 1 , further comprising reducing the population of bacteria that spirochetes depend upon to thrive and grow.

12. The method as set forth in claim 1 , wherein said bacteria comprise P. gingivalis.

13. The method as set forth in claim 1 , further comprising limiting the population of Treponema denticola.

14. A method to facilitate the growth of desired bacteria in a human's mouth to limit the number of pathogenic bacteria, to maintain oral health and to establish a biofilm in a human subject's mouth, comprising,

after a human subject has cleaned their teeth, killing gram negative bacteria that are associated with periodontitis;

providing to the human subject a bacterial composition comprising beneficial bacteria adapted to form a biofilm, said beneficial bacteria comprising a bacterium of the genus Rothia , and wherein said bacterial composition does not inhibit growth of a bacterium of species) Lactobacillus salivarius , and reducing the population of bacteria that spirochetes depend upon to thrive and grow using a clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein (Cas) system or a CRISPR from Prevotella and Francisella 1 (Cpf1) system.

15. The method as set forth in claim 14 , wherein said beneficial bacteria is provided on an oral strip.

16. The method as set forth in claim 14 , wherein said strip has a first side and a second side, said second side having a bioadhesive that is adapted to bind to a mucosal membrane of the human subject for at least 1 hour while inside the human subject's mouth.

17. The method as set forth in claim 14 , wherein said beneficial bacteria further comprises Lactobacillus reuteri in an amount sufficient to induce oxytocin production.

18. The method as set forth in claim 14 , wherein said gram negative bacteria comprises Treponema denticola.

19. The method as set forth in claim 14 , wherein the bacterial composition does not inhibit growth of a second bacterium selected from at least one of the species Streptococcus mutans and Lactobacillus fermentum.

20. The method as set forth in claim 14 , wherein the bacterial composition does not inhibit growth of a bacterium of species Lactobacillus salivarius.

Assignments (3)
SECURITY INTEREST Recorded Jul 21, 2026
From: SEED HEALTH, INC.
To: JPMORGAN CHASE BANK, N.A., AS LENDER
Reel/Frame 076028/0339 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2022
From: KOVARIK, JOE
To: SEED HEALTH, INC.
Reel/Frame 059690/0210 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2021
From: KOVARIK, JOSEPH E
To: KOVARIK, JOSEPH E.
Reel/Frame 057819/0661 →
Continuity (30)
Continuation In Part 15983250 · May 18, 2018
Continuation In Part 15384716 · Dec 20, 2016
Continuation In Part 16904056 · Jun 17, 2020
Continuation In Part 14752192 · Jun 26, 2015
Continuation In Part 14225503 · Mar 26, 2014
Continuation 13367052 · Feb 6, 2012
Continuation 16904056 · Jun 17, 2020
Continuation In Part 15270034 · Sep 20, 2016
Continuation In Part 14954074 · Nov 30, 2015
Continuation In Part 14574517 · Dec 18, 2014
Continuation In Part 16904056 · Jun 17, 2020
Continuation In Part 15228454 · Aug 4, 2016
Continuation In Part 16904056 · Jun 17, 2020
Continuation In Part 14611458 · Feb 2, 2015
Continuation 14502097 · Sep 30, 2014
Continuation 14307651 · Jun 18, 2014
Continuation In Part 14079054 · Nov 13, 2013
Continuation 13425913 · Mar 21, 2012
Provisional Application 62387405 · Dec 24, 2015
Provisional Application 61439652 · Feb 4, 2011
Provisional Application 61566023 · Nov 4, 2011
Provisional Application 62072476 · Oct 30, 2014
Provisional Application 62053926 · Sep 23, 2014
Provisional Application 62014855 · Jun 20, 2014
Provisional Application 61919297 · Dec 20, 2013
Provisional Application 62387404 · Dec 24, 2015
Provisional Application 62274550 · Jan 4, 2016
Provisional Application 62275341 · Jan 6, 2016
Provisional Application 61467767 · Mar 25, 2011
Related Publication 20200323679A1 · Oct 15, 2020
Cited By (7)
US 12,246,043 US 12,257,272 US 12,318,411 US 12,318,414 US 12,329,783 US 12,357,662 US 12,533,312